These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11769715)

  • 1. [Antisense oligodeoxynucleotide of telomerase gene enhances cisplatin-induced apoptosis in acute myeloid leukemia and chronic myeloid leukemia cells].
    He D; Zhang H
    Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):654-6. PubMed ID: 11769715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia.
    Yuan Z; Mei HD
    Hematol J; 2002; 3(4):201-5. PubMed ID: 12189566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of inhibition of telomerase activity on cisplatin-induced apoptosis in K562 cells].
    He D; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):355-8. PubMed ID: 11877097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of human telomerase reverse transcriptase gene antisense oligodeoxynucleotide on telomerase activity in leukemia cells].
    He DM; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):523-6. PubMed ID: 12513713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of antisense oligodeoxynucleotides of RNA component of human telomerase on cisplatin induced apoptosis in K562 cells].
    Xiao Y; Zhang H
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):144-7. PubMed ID: 12581964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
    Fei J; Zhang H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Inhibition of Telomerase on Cisplatin-Induced Apoptosis in HL-60 Cells].
    He DM; Zhang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Sep; 9(3):215-219. PubMed ID: 12578592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of telomerase activity and induction of apoptosis in lung cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide].
    Wang X; Zhang Z; Xu Y; Chen S; Xiong W
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):175-8. PubMed ID: 11940318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.
    Baśkiewicz-Masiuk M; Machaliński B
    Eur J Haematol; 2004 Jun; 72(6):420-9. PubMed ID: 15128421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of hTERT ASODN on the oncogenicity and the inductive apoptosis of HL-60 cells].
    Sun L; Wang F; Sun H; Le XP; Ge XF; Liu LX; Zhang QX
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):386-9. PubMed ID: 17147228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomerase gene antisense oligodeoxynucleotide down-regulates telomerase activity in HL-60 cells].
    He DM; Zhang H
    Ai Zheng; 2002 Oct; 21(10):1070-4. PubMed ID: 12508645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of c-myc antisense oligodeoxynucleotide on the telomerase activity and the induction of apoptosis in HL-60 cells].
    Sun L; Wang F; Sun H; Le XP; Liu LX; Liu YF; Wang F; Wang YH; Ma HY; Zhang QX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):605-9. PubMed ID: 16129043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
    Li L; Keating MJ; Plunkett W; Yang LY
    Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Knock-down of apollon gene by antisense oligodeoxynucleotide inhibits the proliferation of Lovo cells and enhances chemo-sensitivity].
    He JH; Zhang XY; Wu FY; Liao XL; Wang W; Jiang JW
    Yao Xue Xue Bao; 2011 Feb; 46(2):138-45. PubMed ID: 21542283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells.
    Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Bali P; Estrella V; Kumaraswamy S; Rao R; Rocha K; Herger B; Lee F; Richon V; Bhalla K
    Clin Cancer Res; 2006 Oct; 12(19):5869-78. PubMed ID: 17020995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.